Top 10 Consumer Service Companies For 2015: Isis Pharmaceuticals Inc.(ISIS)
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using antisense drug discovery platform. The company?s antisense drug development programs focus on treating cardiovascular, metabolic, cancer, and severe neurodegenerative diseases. It has commercialized antisense drugs and has 24 drugs in development. Isis Pharmaceuticals, through Regulus Therapeutics Inc., also focuses on the discovery, development, and commercialization of microRNA-based therapeutics. The company has strategic alliances and collaboration agreements primarily with GlaxoSmithKline; Genzyme Corporation; Archemix Corp.; Alnylam Pharmaceuticals, Inc.; Bristol-Myers Squibb; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; and Eli Lilly and Company. Isis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Advisors' Opinion:- [By Keith Speights]
Aegerion Pharmaceuticals (NASDAQ: AEGR ) received FDA approval in late 2012 for Juxtapid in the treatment of HoFH. Soon afterward, the FDA approved another drug targeting HoFH, Kynamro, which was developed by Isis Pharmaceuticals (NASDAQ: ISIS ) and marketed by Sanofi's (NYSE: SNY ) Genzyme unit.
source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-10-consumer-service-companies-for-2015.html
No comments:
Post a Comment